These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28694053)

  • 1. Biased signaling of G protein-coupled receptors - From a chemokine receptor CCR7 perspective.
    Jørgensen AS; Rosenkilde MM; Hjortø GM
    Gen Comp Endocrinol; 2018 Mar; 258():4-14. PubMed ID: 28694053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7.
    Jørgensen AS; Larsen O; Uetz-von Allmen E; Lückmann M; Legler DF; Frimurer TM; Veldkamp CT; Hjortø GM; Rosenkilde MM
    Front Immunol; 2019; 10():2156. PubMed ID: 31572374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL19 with CCL21-tail displays enhanced glycosaminoglycan binding with retained chemotactic potency in dendritic cells.
    Jørgensen AS; Adogamhe PE; Laufer JM; Legler DF; Veldkamp CT; Rosenkilde MM; Hjortø GM
    J Leukoc Biol; 2018 Aug; 104(2):401-411. PubMed ID: 29768676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes.
    Hauser MA; Legler DF
    J Leukoc Biol; 2016 Jun; 99(6):869-82. PubMed ID: 26729814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential CCR7 Targeting in Dendritic Cells by Three Naturally Occurring CC-Chemokines.
    Hjortø GM; Larsen O; Steen A; Daugvilaite V; Berg C; Fares S; Hansen M; Ali S; Rosenkilde MM
    Front Immunol; 2016; 7():568. PubMed ID: 28018341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential ligand-signaling network of CCL19/CCL21-CCR7 system.
    Raju R; Gadakh S; Gopal P; George B; Advani J; Soman S; Prasad TS; Girijadevi R
    Database (Oxford); 2015; 2015():. PubMed ID: 26504105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of CCL19 by DC-Lamp+ mature dendritic cells in human lymph node versus chronically inflamed skin.
    Katou F; Ohtani H; Nakayama T; Nagura H; Yoshie O; Motegi K
    J Pathol; 2003 Jan; 199(1):98-106. PubMed ID: 12474232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C-terminal peptide of CCL21 drastically augments CCL21 activity through the dendritic cell lymph node homing receptor CCR7 by interaction with the receptor N-terminus.
    Jørgensen AS; Brandum EP; Mikkelsen JM; Orfin KA; Boilesen DR; Egerod KL; Moussouras NA; Vilhardt F; Kalinski P; Basse P; Chen YH; Yang Z; Dwinell MB; Volkman BF; Veldkamp CT; Holst PJ; Lahl K; Goth CK; Rosenkilde MM; Hjortø GM
    Cell Mol Life Sci; 2021 Nov; 78(21-22):6963-6978. PubMed ID: 34586443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Boosting of CCR7-Acting Chemokines; Short Peptides Boost Chemokines with Short Basic Tails, Longer Peptides Boost Chemokines with Long Basic Tails.
    Brandum EP; Jørgensen AS; Calvo MB; Spiess K; Peterson FC; Yang Z; Volkman BF; Veldkamp CT; Rosenkilde MM; Goth CK; Hjortø GM
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A myriad of functions and complex regulation of the CCR7/CCL19/CCL21 chemokine axis in the adaptive immune system.
    Comerford I; Harata-Lee Y; Bunting MD; Gregor C; Kara EE; McColl SR
    Cytokine Growth Factor Rev; 2013 Jun; 24(3):269-83. PubMed ID: 23587803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19.
    Haessler U; Pisano M; Wu M; Swartz MA
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5614-9. PubMed ID: 21422278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21.
    Byers MA; Calloway PA; Shannon L; Cunningham HD; Smith S; Li F; Fassold BC; Vines CM
    J Immunol; 2008 Oct; 181(7):4723-32. PubMed ID: 18802075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct CCR7 glycosylation pattern shapes receptor signaling and endocytosis to modulate chemotactic responses.
    Hauser MA; Kindinger I; Laufer JM; Späte AK; Bucher D; Vanes SL; Krueger WA; Wittmann V; Legler DF
    J Leukoc Biol; 2016 Jun; 99(6):993-1007. PubMed ID: 26819318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2.
    Scandella E; Men Y; Legler DF; Gillessen S; Prikler L; Ludewig B; Groettrup M
    Blood; 2004 Mar; 103(5):1595-601. PubMed ID: 14592837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7.
    Kohout TA; Nicholas SL; Perry SJ; Reinhart G; Junger S; Struthers RS
    J Biol Chem; 2004 May; 279(22):23214-22. PubMed ID: 15054093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin Specifically Interacts with Basic BBXB Motifs of the Chemokine CCL21 to Define CCR7 Signaling.
    Artinger M; Gerken OJ; Legler DF
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Assessment of Human CCR7 Signalling Using NanoBRET Biosensors Points towards the Importance of the Cellular Context.
    Vanalken N; Boon K; Szpakowska M; Chevigné A; Schols D; Van Loy T
    Biosensors (Basel); 2024 Mar; 14(3):. PubMed ID: 38534251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial guidance by CCR7 ligands for T lymphocytes migration in co-existing chemokine fields.
    Nandagopal S; Wu D; Lin F
    PLoS One; 2011 Mar; 6(3):e18183. PubMed ID: 21464944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
    Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
    Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR7 Sulfotyrosine Enhances CCL21 Binding.
    Phillips AJ; Taleski D; Koplinski CA; Getschman AE; Moussouras NA; Richard AM; Peterson FC; Dwinell MB; Volkman BF; Payne RJ; Veldkamp CT
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28841151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.